SCM
MRK icon

SCS Capital Management’s Merck MRK Stock Holding History

SCS Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.84M Sell
21,998
-615
-3% -$72K 0.03% 193
2026
Q1 		$2.73M Sell
22,613
-704
-3% -$81.3K 0.03% 186
2025
Q4 		$2.47M Buy
23,317
+444
+2% +$41.7K 0.03% 198
2025
Q3 		$1.93M Sell
22,873
-1,204
-5% -$99.2K 0.02% 216
2025
Q2 		$1.92M Sell
24,077
-437
-2% -$34.7K 0.02% 226
2025
Q1 		$2.21M Buy
+24,514
New +$2.29M 0.03% 193

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SCS Capital Management's MRK Position: Q2 2026 in Review

SCS Capital Management reduced its Merck (MRK) stake by 2.7% in Q2 2026, selling an estimated $72K and leaving 21,998 shares worth $2.84M. The position accounts for 0.03% of the portfolio, ranked #193.

SCS Capital Management first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • SCS Capital Management held 21,998 shares of Merck worth $2.84M as of Q2 2026.
  • SCS Capital Management sold 615 Merck shares in Q2 2026, an estimated $72K.
  • Merck made up 0.03% of SCS Capital Management's portfolio in Q2 2026, its #193 holding.
  • SCS Capital Management first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on SCS Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.